LIFR and neoplasm: In the nucleus, nPAK4 suppresses the expression of leukemia inhibitory factor receptor (LIFR), a key ERα target gene responsible for maintaining the dormant state of disseminated tumor cells (DTCs) in the bone marrow niche [33].